Nuevo Usuario

Recordar Contraseña

Revista de Osteoporosis y Metabolismo Mineral 00005 / http://dx.doi.org/10.20960/RevOsteoporosMetabMiner.00005

Resumen| PDF (ENGLISH)

Trabajo Original

Osteoclast generation from RAW 264.7 and PBMC cells. The set up in our lab

Susana Jurado, Albert Parés, Pilar Peris, Andrés Combalia, Ana Monegal Brancos, Nuria Guañabens

Prepublicado: 2023-03-28

Publicado: 2023-03-28

VOLUMEN 15, NÚM. 1, enero-marzo (2023), PAG. 6-11

Logo Descargas Número de descargas: 373 Logo Visitas Número de visitas: 2171 Citas Citas: 0

Compártelo:

Introduction and objectives: osteoclasts are terminally differentiated giant multinucleated cells derived from the fusion of mononuclear progenitors of the monocyte/macrophage hematopoietic lineage. The objective of our group was to achieve the best method for osteoclast differentiation, from both RAW 264.7 cells and peripheral blood monocytes. Material and methods: RAW 264.7 cells and human PBMCs were differentiated into osteoclasts. Success in differentiation was assessed by TRAP staining. Osteoclast activity was detected by the resorption pits in Corning® Osteo Assay Surface Plates. Results: the optimal cell density for RAW 264.7 cell differentiation was 25,000 cells/cm2 with 30 ng/mL of RANKL for 6 days. Osteoclasts differentiated from PBMCs were observed after 4 weeks with 25 ng/mL M-CSF and 30 ng/mL RANKL. Individual pits or multiple pit clusters were observed on the surface plates. Conclusions: we report optimal conditions for the differentiation of osteoclasts from RAW 264.7 and PBMCs cells to carry out our future experiments.

Palabras Clave: Osteoclasts. Differentiation. Bone resorption.

Descargar PDF

Bibliografía

Charles JF, Aliprantis AO. Osteoclasts: more than `bone eaters´.’ Trends Mol Med 2014;20(8):449-59.
DOI: 10.1016/j.molmed.2014.06.001

Khosla S. Minireview: The OPG/RANKL/RANK System. Endocrinology 2001;142(12):5050-5.
DOI: 10.1210/endo.142.12.8536

Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423(6937):337-42.
DOI: 10.1038/nature01658

McDonald MM, Khoo WH, Ng PY, Xiao Y, Zamerli J, Thatcher P, et al. Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption. Cell 2021;184(5):1330-1347.e13.
DOI: 10.1016/j.cell.2021.02.002

Nguyen J, Nohe A. Factors that Affect the Osteoclastogenesis of RAW264.7 Cells. J Biochem Anal Stud 2017;2(1):10.16966/2576-5833.109.
DOI: 10.16966/2576-5833.109

Song C, Yang X, Lei Y, Zhang Z, Smith W, Yan J, et al. Evaluation of efficacy on RANKL induced osteoclast from RAW264.7 cells. J Cell Physiol 2019;234(7):11969-75.
DOI: 10.1002/jcp.27852

Abdallah D, Jourdain M-L, Braux J, Guillaume C, Gangloff SC, Jacquot J, et al. An Optimized Method to Generate Human Active Osteoclasts from Peripheral Blood Monocytes. Front Immunol 2018;9:632.
DOI: 10.3389/fimmu.2018.00632

Jurado S, Parés A, Peris P, Combalia A, Monegal A, Guañabens N. Bilirubin increases viability and decreases osteoclast apoptosis contributing to osteoporosis in advanced liver diseases. Bone 2022;162:116483.
DOI: 10.1016/j.bone.2022.116483

Wright LE, Buijs JT, Kim H-S, Coats LE, Scheidler AM, John SK, et al. Single-Limb Irradiation Induces Local and Systemic Bone Loss in a Murine Model. J Bone Miner Res 2015;30(7):1268-79.
DOI: 10.1002/jbmr.2458